$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > Pemigatinib

靶点|FGFR

FGFR靶向药的研发进展
  • FGFR靶向药的研发进展
  • FGFRs是受体酪氨酸激酶RTKs超家族的成员,通过与配体FGFs结合并激活下游信号通路参与多种生物学过程的调控,如器官发育、血管生新生、细胞增殖、迁移、抗凋亡等。肿瘤中往往发...|阅读全文
  • 发布日期 2020-07-30 07:56:33